DUCHENE TODD M 4

What Happened
Todd M. Duchene, Core Scientific’s Chief Legal and Administrative Officer, sold a total of 10,000 shares in open-market transactions on May 11, 2026, for aggregate proceeds of approximately $232,420. The filing breaks the sales into: 2,600 shares at a weighted-average price of $22.82 (proceeds $59,322) and 7,400 shares at a weighted-average price of $23.39 (proceeds $173,098). These were sales (S) — not purchases — and thus are not a direct bullish signal; they appear to have been executed under a pre-established trading plan.

Key Details

• Transaction date: May 11, 2026 (filed May 13, 2026 — appears timely).
• Reported prices: weighted-average $22.82 (2,600 sh; range $22.13–$23.11) and $23.39 (7,400 sh; range $23.13–$23.72).
• Total shares sold: 10,000; total proceeds: ~$232,420.
• Shares owned after transaction: Not specified in the provided filing details.
• Notable footnotes: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 5, 2025; the reported prices are weighted averages and were achieved via multiple trades within the stated price ranges.
• Transaction code: S = Sale.

Context
Sales under a 10b5-1 plan are typically pre-set instructions that allow insiders to sell shares on a scheduled basis and are commonly treated as routine liquidity events rather than direct statements about company prospects. No options were exercised and no gifts or tax-withholding events were reported in this filing.